Calamos Advisors’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-305,303	Closed	-$12.9M	–	1013
2023 Q4	$12.9M	Buy	+305,303	New	+$12.9M	0.06%	321